GO:1905607 negative regulation of presynapse assembly

The assembly of presynaptic terminals is a fundamental step in neural circuit formation. It involves the coordinated recruitment of synaptic vesicles, active zone proteins, and cytoskeletal elements to nascent axon terminals. To prevent excessive or ectopic synapse formation, neurons employ negative regulatory mechanisms that stop, prevent, or reduce presynapse assembly. This process is captured by the Gene Ontology term GO:1905607, negative regulation of presynapse assembly. Understanding this term is critical for researchers studying synaptic development, neural connectivity, and disorders characterized by synaptic dysfunction. Negative regulation of presynapse assembly ensures that synapses form at the right time and place, and its disruption can lead to aberrant connectivity. For example, Wnt signaling acts as a positional cue that inhibits synapse formation at specific neuromuscular junctions in C. elegans, demonstrating that negative regulation is essential for proper wiring. Similarly, presynaptic scaffold proteins such as Bassoon modulate proteasome activity, which in turn affects presynaptic structure and function. These findings highlight that negative regulation of presynapse assembly is not merely a brake but an instructive process that shapes neural circuits. Researchers interested in neurodevelopment, synaptic plasticity, and neurodegeneration need to understand the molecular players and experimental approaches for studying GO:1905607. This article provides a comprehensive overview based on authoritative QuickGO data and verified PubMed literature, covering the definition, mechanisms, key genes, disease relevance, and research methods including CRISPR-based models.

GO:1905607, negative regulation of presynapse assembly, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of presynapse assembly. In other words, it encompasses molecular and cellular events that inhibit the formation of presynaptic terminals, which are the specialized structures at axon endings that release neurotransmitters. This regulation can occur at various stages, from the initial recruitment of synaptic components to the stabilization of nascent synapses. It is a biological process that ensures appropriate synapse numbers and prevents aberrant connectivity.

Negative regulation of presynapse assembly is crucial for proper neural circuit formation and function. Without it, neurons may form excessive or ectopic synapses, leading to disrupted signaling and neurological disorders. This process ensures that synapses are formed only at appropriate locations and times, contributing to the precision of neural wiring. Moreover, presynaptic assembly is energetically demanding, and its negative regulation helps conserve resources and maintain synaptic homeostasis. Understanding GO:1905607 provides insights into fundamental neurodevelopmental mechanisms and may reveal therapeutic targets for conditions characterized by synaptic abnormalities, such as autism spectrum disorders, schizophrenia, and neurodegenerative diseases [1,3].

The following genes and proteins have been implicated in negative regulation of presynapse assembly or related processes, based on verified literature.

Negative regulation of presynapse assembly is itself regulated by various signaling pathways. Wnt signaling is a well-characterized example: it positions neuromuscular connectivity by inhibiting synapse formation in C. elegans. Additionally, the interaction between Bassoon and PSMB4 suggests that proteasome activity is modulated to control presynaptic protein turnover, thereby influencing presynapse assembly. Kinesin-dependent microtubular transport is another point of regulation, as slow transport facilitates ribbon synapse assembly, and altering transport efficiency could negatively regulate assembly. These regulatory mechanisms ensure that presynapse assembly is tightly controlled in space and time.

Disruption of negative regulation of presynapse assembly can lead to aberrant synapse formation, which is implicated in neurodevelopmental disorders such as autism spectrum disorders and schizophrenia. For example, mutations in presynaptic scaffold proteins like Bassoon have been associated with synaptic dysfunction. Wnt signaling components, which inhibit synapse formation, are also linked to neurodevelopmental phenotypes.

Synapse loss is a hallmark of neurodegenerative diseases including Alzheimer's disease and Parkinson's disease. Dysregulation of mechanisms that normally inhibit presynapse assembly could contribute to synaptic pathology. Bassoon and proteasome dysfunction have been observed in neurodegenerative contexts. Understanding how negative regulation of presynapse assembly is altered in these diseases may reveal new therapeutic targets.

Ribbon synapse assembly in cochlear inner hair cells is essential for hearing. Slow kinesin-dependent microtubular transport facilitates this assembly, and its perturbation could lead to hearing loss. Negative regulation of presynapse assembly may be involved in fine-tuning ribbon synapse formation, and its dysregulation could contribute to auditory neuropathy.

Confocal and super-resolution microscopy can visualize presynaptic terminals using markers such as Bassoon, synaptophysin, and VAMP2. These methods allow quantification of synapse number, size, and density, which are readouts of presynapse assembly and its negative regulation.

Patch-clamp recordings and extracellular field potential recordings measure synaptic transmission and plasticity. Reduced presynapse assembly would manifest as decreased synaptic responses, providing functional evidence of negative regulation.

Mass spectrometry-based proteomics can identify protein interactions and post-translational modifications. For example, the interaction between Bassoon and PSMB4 was identified using biochemical approaches. Proteomics can reveal changes in presynaptic protein composition upon negative regulation.

RNA sequencing can measure gene expression changes during negative regulation of presynapse assembly. This helps identify transcriptional programs that inhibit synapse formation and potential regulators.

Researchers studying negative regulation of presynapse assembly-related genes often need to determine whether a candidate gene is causally involved in this process. CRISPR-based models provide a robust way to manipulate genes and assess their effects on synapse formation. EDITGENE offers a comprehensive suite of services to support such studies, from knockout to overexpression and library screening.

GO:1905607, negative regulation of presynapse assembly, is a critical biological process that ensures proper neural circuit formation by preventing excessive or ectopic synapse formation. Key molecular players such as Bassoon, Wnt signaling components, and kinesin motors have been identified through studies in various model systems [1,2,3]. Dysregulation of this process is implicated in neurodevelopmental and neurodegenerative disorders, making it a promising area for therapeutic intervention. Researchers can leverage CRISPR-based models and advanced imaging, electrophysiology, and omics methods to further unravel the mechanisms and disease relevance of this process. EDITGENE provides comprehensive services to support such investigations.